Loading... Please wait...
  • Image 1

Streptavidin: SureLight® APC protein assay format, 1mg


Product Description

Streptavidin conjugated to SureLight® APC - Optimized for protein interaction assays, 1mg


Item# D3-2212-P01
Binding Moiety
SureLight® Allophycocyanin
Excitation max. λ
Emission max. λ
Optimized for High throughput screening (HTS) and fluorescence resonance energy transfer (FRET) assays targeting protein interactions, flow cytometry
Form and Storage
Lyophilized, Store at 4° C.
Upon reconstitution, product should be stored at 4° C and used within 8 months.
Technical Info
Technical Data Sheet   Safety Data Sheet (SDS)

Auclair, D., Miller, D., Yatsula, V., Pickett, W., Carter, C., Chang, Y., et al. (2007). Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia (Vol. 21).

Bamborough, P., Angell, R. M., Bhamra, I., Brown, D., Bull, J., Christopher, J. A., et al. (2007). N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: Indazoles as phenol isosteres with improved pharmacokinetics. Bioorganic & Medicinal Chemistry Letters (Vol. 17).

Barrios Sosa, A. C., Boschelli, D. H., Ye, F., Golas, J. M., & Boschelli, F. (2004). Synthesis and inhibition of Src kinase activity by 7-ethenyl and 7-ethynyl-4-anilino-3-quinolinecarbonitriles. Bioorganic & Medicinal Chemistry Letters (Vol. 14).

Coward, P., Conn, M., Tang, J., Xiong, F., Menjares, A., & Reagan, J. D. (2009). Application of an allosteric model to describe the interactions among retinol binding protein 4, transthyretin, and small molecule retinol binding protein 4 ligands. Anal Biochem (Vol. 384).

Day, J. E. H., Sharp, S. Y., Rowlands, M. G., Aherne, W., Workman, P., & Moody, C. J. (2010). Targeting the Hsp90 chaperone: synthesis of novel resorcylic acid macrolactone inhibitors of Hsp90. Chemistry (Vol. 16).

Drake, K. A., Zhang, J. - H., Harrison, R. K., & McGeehan, G. M. (2002). Development of a homogeneous, fluorescence resonance energy transfer-based in vitro recruitment assay for peroxisome proliferator-activated receptor delta via selection of active LXXLL coactivator peptides. Anal Biochem (Vol. 304).

Kane, C. D., Stevens, K. A., Fischer, J. E., Haghpassand, M., Royer, L. J., Aldinger, C., et al. (2009). Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor {alpha} Agonists with Robust Hypolipidemic Activity in Vivo. Mol Pharmacol (Vol. 75).

Lee, G., Elwood, F., McNally, J., Weiszmann, J., Lindstrom, M., Amaral, K., et al. (2002). T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J Biol Chem (Vol. 277).

Li, Y., Wang, Z., Furukawa, N., Escaron, P., Weiszmann, J., Lee, G., et al. (2008). T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties. J Biol Chem (Vol. 283).

Liu, J., Knappenberger, K. S., Kack, H., Andersson, G., Nilsson, E., Dartsch, C., et al. (2003). A Homogeneous in Vitro Functional Assay for Estrogen Receptors: Coactivator Recruitment. Mol Endocrinol (Vol. 17).

Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., et al. (1999). Identification of a Nuclear Receptor for Bile Acids. Science (Vol. 284).

Najima, Y., Yahagi, N., Takeuchi, Y., Matsuzaka, T., Sekiya, M., Nakagawa, Y., et al. (2005). High Mobility Group Protein-B1 Interacts with Sterol Regulatory Element-binding Proteins to Enhance Their DNA Binding. J Biol Chem (Vol. 280).

Ohshima, A., Takamatsu, Y., & Saitoh, H. (2010). Efficient Selection of Cell Clones with Higher Productivity in the Production of Recombinant Human Monoclonal Antibodies. JAACT: Basic and Applied Aspects.

Porter, J., Payne, A., Whitcombe, I., de Candole, B., Ford, D., Garlish, R., et al. (2009). Atropisomeric small molecule Bcl-2 ligands: Determination of bioactive conformation. Bioorganic & Medicinal Chemistry Letters (Vol. 19).

So, C. H., Verma, V., Alijaniaram, M., Cheng, R., Rashid, A. J., O'Dowd, B. F., et al. (2009). Calcium Signaling by Dopamine D5 Receptor and D5-D2 Receptor Hetero-Oligomers Occurs by a Mechanism Distinct from That for Dopamine D1-D2 Receptor Hetero-Oligomers. Mol Pharmacol (Vol. 75).

Tremblay, G. B., Kunath, T., Bergeron, D., Lapointe, L., Champigny, C., Bader, J. A., et al. (2001). Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. Genes & Development (Vol. 15).

Wickens, P., Kluender, H., Dixon, J., Brennan, C., Achebe, F., Bacchiocchi, A., et al. (2007). SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters (Vol. 17).

Wood, E. R., Shewchuk, L., Hassel, A., Nichols, J., Truesdale, A. T., Smith, D., et al. (2009). Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: Implications for cellular potency and selectivity over insulin receptor. Biochemical Pharmacology.

Zhang, W. X., Wang, R., Wisniewski, D., Marcy, A. I., LoGrasso, P., Lisnock, J. - M., et al. (2005). Time-resolved Forster resonance energy transfer assays for the binding of nucleotide and protein substrates to p38alpha protein kinase. Anal Biochem (Vol. 343).

Zhou, V., Han, S., Brinker, A., Klock, H., Caldwell, J., & Gu, X. -ju. (2004). A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors. Anal Biochem (Vol. 331).

Ziegler, D. S., Wright, R. D., Kesari, S., Lemieux, M. E., Tran, M. A., Jain, M., et al. (2008). Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins. J Clinical Investigation (Vol. 118).



Product Reviews

Write Review

This product hasn't received any reviews yet. Be the first to review this product!